Renvela and Ipratropium bromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Renvela (sevelamer carbonate) and Ipratropium bromide (ipratropium bromide). Common drug interactions include chronic kidney disease among females and bacterial infection among males.

The phase IV clinical study analyzes what interactions people have when they take Renvela and Ipratropium bromide. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Renvela?

Renvela has active ingredients of sevelamer carbonate. eHealthMe is studying from 10,923 Renvela users. Check the latest studies of Renvela.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

On Aug, 01, 2026

22 people who take Renvela and Ipratropium bromide together, and have interactions are studied.

Renvela and Ipratropium bromide drug interactions.

What are the common drug interactions of Renvela and Ipratropium Bromide, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Death
Pneumonia
Abdominal distension
Anaemia (lack of blood)
Bacteraemia (presence of bacteria in the blood)
Blood glucose increased

male:

Bacterial infection
Gallbladder operation
Cough
Death
Emotional distress
Fall
Foaming at mouth (excess saliva secretion)
Fracture
Heart rate irregular
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

What are the common drug interactions of Renvela and Ipratropium Bromide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaemia (lack of blood)
Bacteraemia (presence of bacteria in the blood)
Blood pressure decreased
Blood urine present
Cholecystitis (infection of gallbladder)
Chronic kidney disease
Dizziness
Haematoma (collection of blood outside the blood vessels)
Haematuria (presence of blood in urine)
Hydronephrosis (water inside the kidney)

50-59:

Asthenia (weakness)
Bacterial infection
Cellulitis (infection under the skin)
Cough
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Neutropenia (an abnormally low number of neutrophils)
Respiratory syncytial virus test positive

60+:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Coma (state of unconsciousness lasting more than six hours)
Foaming at mouth (excess saliva secretion)
Fracture
Heart rate irregular
Hip fracture
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Respiratory failure (inadequate gas exchange by the respiratory system)
Nephrogenic anaemia (anaemia due to kidney disease)

What are the existing conditions these people have? *

Hyperkalemia (damage to or disease of the kidney): 8 people, 36.36%
High Blood Pressure: 4 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.64%
Cardiac Failure Congestive: 3 people, 13.64%
High Blood Cholesterol: 3 people, 13.64%
Diabetes: 3 people, 13.64%
Dyspnea (difficult or laboured breathing): 2 people, 9.09%
Constipation: 2 people, 9.09%
Cough: 2 people, 9.09%
Diarrhea: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Renvela and Ipratropium bromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously